Zymergen Overview
- Founded
- 2013
- Status
- Private
- Employees
- 732
- Latest Deal Type
- Series D
- Latest Deal Amount
- $300M
- Investors
- 48
Zymergen General Information
Description
Developer of molecular technology intended to discover and deliver novel products and materials. The company's platform integrates artificial intelligence algorithms and robotic genomic to search the microbial genome and identify paths that human scientists cannot discover, thereby enabling companies to discover impossible new materials, commercialize new products and improve the economics of existing bio-manufactured products.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Materials
Primary Office
- 5980 Horton Street
- Suite 105
- Emeryville, CA 94608
- United States
+1 (415) 000-0000
Zymergen Timeline
Zymergen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series D) | 08-Sep-2020 | $300M | 00000 | 00.000 | Completed | Generating Revenue |
| 7. Later Stage VC (Series C) | 13-Dec-2018 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 6. Early Stage VC (Series B) | 29-Nov-2017 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
| 5. Early Stage VC (Series B) | 07-Oct-2016 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A) | 04-Jun-2015 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Seed Round | 01-May-2014 | 000 | 000 | Completed | Stealth | |
| 2. Seed Round | 01-Jun-2013 | $2M | $2M | Completed | Stealth | |
| 1. Accelerator/Incubator | Completed | Stealth |
Zymergen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | 00,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 26,158,833 | $0.001000 | $0.02 | $0.25 | $0.25 | 1x | $0.25 | 9.5% |
| Series A | 21,998,250 | $0.001000 | $0.13 | $1.66 | $1.66 | 1x | $1.66 | 7.99% |
Zymergen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular technology intended to discover and deliver novel products and materials. The company's platform
Biotechnology
Emeryville, CA
732
As of 2020
00000
0.000
0000-00-00
00000000000
00000
00000
smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
000000000000 000000000
Berkeley, CA
00
As of 0000
000.00
000000000 -
000.00
00000000
modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000 000000000
Berkeley, CA
00
As of 0000
0000
00000000000
0000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialZymergen Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lygos | Venture Capital-Backed | Berkeley, CA | 00 | 000.00 | 000000000 - | 000.00 |
| 00000000 | Venture Capital-Backed | Berkeley, CA | 00 | 0000 | 00000000000 | 0000 |
| 0000000 | Corporation | Roslin, United Kingdom | 0 | 0000000000 | ||
| 000000 00000000 | Venture Capital-Backed | Boston, MA | 000 | 00000 | 00000000000 | 00000 |
| 000000 | Venture Capital-Backed | Seattle, WA | 0 | 000.00 | 000000000 - | 000.00 |
Zymergen Executive Team (16)
Zymergen Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dipchand Nishar | SoftBank Group | Board Member | 000 0000 |
| Jay Flatley | Self | Board Member | 000 0000 |
| Jed Dean Ph.D | Zymergen | Co-Founder, Board Member & Vice President, Operations and Engineering | 000 0000 |
| Joshua Hoffman | Zymergen | Co-Founder, Board Member & Chief Executive Officer | 000 0000 |
| Matthew Ocko | Data Collective | Board Member | 000 0000 |
Zymergen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialZymergen Investors (48)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Baillie Gifford | Asset Manager | Minority | 000 0000 | 000000 0 | |
| Baron Funds | Asset Manager | Minority | 000 0000 | 000000 0 | |
| DCVC Bio | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Perceptive Advisors | Hedge Fund | Minority | 000 0000 | 000000 0 | |
| SciFi VC | Venture Capital | Minority | 000 0000 | 000000 0 |
Zymergen Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 19-Mar-2020 | 000000000000000000 | Other Commercial Products | 000000 0000000 | |
| Radiant Genomics | 08-Jan-2018 | Merger/Acquisition | Other Commercial Services | 000000 0000000 |
Zymergen Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 00000000 | Other Commercial Services | Emeryville, CA | 0000 |